The present invention relates to spiroindoline modulators of muscarinic receptors. The present invention also provides compositions comprising such spiroindoline modulators, and methods therewith for treating muscarinic receptor mediated diseases.
Novel reactions of substituted 1-aza-4-oxobutadienes (α-iminoketones) with diorganozinc reagents. Selective ethyl transfer in the Et2Zn/t-BuNC(H)C(Me)O system and x-ray crystal structure of [EtZ]2
作者:M.Robert P. Van Vliet、Johann T.B.H. Jastrzebski、Gerard Van Koten、Kees Vrieze、Anthony L. Spek
DOI:10.1016/0022-328x(83)80256-3
日期:1983.7
US8258148B2
申请人:——
公开号:US8258148B2
公开(公告)日:2012-09-04
Van Vliet, M. Robert P.; Van Koten, Gerard; Buysingh, Paul, Organometallics, 1987, vol. 6, # 3, p. 537 - 546
作者:Van Vliet, M. Robert P.、Van Koten, Gerard、Buysingh, Paul、Jastrzebski, Johann T. B. H.、Spek, Anthony L.